Close Menu

NEW YORK – Monte Rosa Therapeutics on Friday said it has closed a $95 million Series C funding round led by Avoro Capital Advisors.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.